Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Change in Receivables (2021 - 2025)

Intelligent Bio Solutions has reported Change in Receivables over the past 4 years, most recently at $97067.0 for Q1 2024.

  • For Q1 2024, Change in Receivables rose 1971.71% year-over-year to $97067.0; the TTM value through Mar 2024 reached $63852.0, down 78.43%, while the annual FY2023 figure was $293861.0, 116.07% up from the prior year.
  • Change in Receivables for Q1 2024 was $97067.0 at Intelligent Bio Solutions, up from -$304676.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $674984.0 in Q4 2021 and troughed at -$2.5 million in Q3 2021.
  • A 4-year average of -$163221.1 and a median of -$2188.0 in 2023 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: tumbled 167.92% in 2023 and later soared 1971.71% in 2024.
  • Year by year, Change in Receivables stood at $674984.0 in 2021, then plummeted by 33.54% to $448567.0 in 2022, then plummeted by 167.92% to -$304676.0 in 2023, then skyrocketed by 131.86% to $97067.0 in 2024.
  • Business Quant data shows Change in Receivables for INBS at $97067.0 in Q1 2024, -$304676.0 in Q4 2023, and $273649.0 in Q3 2023.